TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 69 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2022. The put-call ratio across all filers is 2.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,002,099 | +122.7% | 53,092 | +124.0% | 0.00% | – |
| Q2 2023 | $898,942 | -18.2% | 23,700 | -47.5% | 0.00% | – |
| Q1 2023 | $1,098,655 | -14.4% | 45,175 | +2.2% | 0.00% | – |
| Q4 2022 | $1,284,207 | -23.2% | 44,222 | -20.7% | 0.00% | – |
| Q3 2022 | $1,672,000 | -15.4% | 55,795 | +2.0% | 0.00% | – |
| Q2 2022 | $1,977,000 | +340.3% | 54,705 | +427.0% | 0.00% | – |
| Q1 2022 | $449,000 | -45.6% | 10,381 | -37.0% | 0.00% | – |
| Q4 2021 | $825,000 | -66.7% | 16,468 | -57.7% | 0.00% | – |
| Q3 2021 | $2,479,000 | -29.7% | 38,976 | -20.5% | 0.00% | – |
| Q2 2021 | $3,527,000 | +218.3% | 49,013 | +226.0% | 0.00% | – |
| Q1 2021 | $1,108,000 | -64.7% | 15,034 | -64.8% | 0.00% | – |
| Q4 2020 | $3,137,000 | +1.8% | 42,721 | -23.9% | 0.00% | -100.0% |
| Q3 2020 | $3,081,000 | -12.0% | 56,173 | +6.7% | 0.00% | 0.0% |
| Q2 2020 | $3,500,000 | +82.9% | 52,659 | +68.4% | 0.00% | 0.0% |
| Q1 2020 | $1,914,000 | -1.3% | 31,277 | +41.9% | 0.00% | – |
| Q4 2019 | $1,939,000 | +44.4% | 22,049 | +23.9% | 0.00% | – |
| Q3 2019 | $1,343,000 | -57.1% | 17,791 | -51.4% | 0.00% | -100.0% |
| Q2 2019 | $3,130,000 | +144.7% | 36,644 | +209.9% | 0.00% | – |
| Q1 2019 | $1,279,000 | +85.4% | 11,824 | +45.0% | 0.00% | – |
| Q4 2018 | $690,000 | -89.0% | 8,152 | -87.3% | 0.00% | -100.0% |
| Q3 2018 | $6,293,000 | -24.3% | 64,006 | -10.9% | 0.00% | 0.0% |
| Q2 2018 | $8,315,000 | +108.3% | 71,865 | +77.8% | 0.00% | +100.0% |
| Q1 2018 | $3,991,000 | -49.9% | 40,417 | -46.8% | 0.00% | -50.0% |
| Q4 2017 | $7,961,000 | +337.7% | 76,022 | +370.9% | 0.00% | +100.0% |
| Q3 2017 | $1,819,000 | -63.8% | 16,145 | -64.0% | 0.00% | -50.0% |
| Q2 2017 | $5,020,000 | -54.9% | 44,801 | -53.0% | 0.00% | 0.0% |
| Q1 2017 | $11,126,000 | +46.9% | 95,398 | +32.6% | 0.00% | +100.0% |
| Q4 2016 | $7,576,000 | -9.5% | 71,948 | -5.0% | 0.00% | -66.7% |
| Q3 2016 | $8,370,000 | +2231.5% | 75,739 | +2976.3% | 0.00% | – |
| Q2 2016 | $359,000 | -93.6% | 2,462 | -93.7% | 0.00% | -100.0% |
| Q1 2016 | $5,613,000 | -8.2% | 39,188 | -0.9% | 0.00% | 0.0% |
| Q4 2015 | $6,113,000 | +7.0% | 39,555 | -1.1% | 0.00% | 0.0% |
| Q3 2015 | $5,713,000 | +6.6% | 39,982 | +7.2% | 0.00% | 0.0% |
| Q2 2015 | $5,357,000 | +0.8% | 37,280 | -1.0% | 0.00% | 0.0% |
| Q1 2015 | $5,312,000 | -52.8% | 37,664 | -50.4% | 0.00% | -50.0% |
| Q4 2014 | $11,255,000 | -13.3% | 75,950 | -10.0% | 0.00% | -20.0% |
| Q3 2014 | $12,980,000 | +58.9% | 84,361 | +44.8% | 0.01% | +66.7% |
| Q2 2014 | $8,171,000 | -3.9% | 58,267 | -24.0% | 0.00% | -25.0% |
| Q1 2014 | $8,507,000 | +318.2% | 76,649 | +272.8% | 0.00% | +300.0% |
| Q4 2013 | $2,034,000 | +24.0% | 20,563 | -4.7% | 0.00% | 0.0% |
| Q3 2013 | $1,640,000 | +90.3% | 21,574 | +40.1% | 0.00% | – |
| Q2 2013 | $862,000 | – | 15,404 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |